Snowball today | 雪球

Beijing Stock Exchange has two main lines of investment: speculation in new stocks and valuation repair!

I haven’t written an article for several days, and Zhulu Jun has spent most of this year worrying about the liquidity of the New Third Board and the Beijing Stock Exchange. The liquidity of the New Third Board has been vacated with the weakening of the general market, and the withdrawal of a large number

Beijing Stock Exchange has two main lines of investment: speculation in new stocks and valuation repair! Read More »

The Price Paradox of Granular Silicon

In the 2022 semi-annual report, GCL disclosed for the first time some basic information about granular silicon, including data on production capacity, output, power consumption, steam consumption, and gross profit from sales. First, the basic situation of granular silicon 1. Capacity and output The production capacity of granular silicon will be 60,000 tons by June

The Price Paradox of Granular Silicon Read More »

Medical devices, looking at the impact of centralized collection results from two standards

Original userfield deployment investment2022-10-18 Medicine has recently experienced a violent backlash. It is said that where there is oppression, there is resistance. The early stage of medical equipment was the most sluggish, and this round became the leader of the rebound. From the beginning of the centralized procurement of coronary stents, medical devices have become

Medical devices, looking at the impact of centralized collection results from two standards Read More »

A brief description of position allocation in the pharmaceutical industry (Q3, 2022)

The pharmaceutical industry belongs to the rigid needs of human beings and is an industry with sustainable growth. The long-term return rate of the industry is the top two in the stock market, and it is one of the must-have directions for my long-term investment. The overestimation in the industry may be 5-10% of the

A brief description of position allocation in the pharmaceutical industry (Q3, 2022) Read More »

After a long absence, the surge, the short-term view is oversold and rebound, and the long-term view is new growth

Original userfield deployment investment2022-10-16 Last Friday, the pharmaceutical sector ushered in a rare violent rise in recent years. According to the paragraph, the difference between the daily limit is only a 10% increase or a 20% increase. In the early stage, the pharmaceutical index continued to be sluggish, and the market felt that there were

After a long absence, the surge, the short-term view is oversold and rebound, and the long-term view is new growth Read More »